D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma
暂无分享,去创建一个
J. Mulliken | A. Perez-Atayde | H. Kozakewich | M. Liang | L. Debelenko | T. Archibald | Tonora H Archibald | Tonora H. Archibald
[1] M. Mihm,et al. Infantile hemangiomas are arrested in an early developmental vascular differentiation state , 2004, Modern Pathology.
[2] E. Kaiserling. [Immunohistochemical identification of lymph vessels with D2-40 in diagnostic pathology]. , 2004, Der Pathologe.
[3] E. Kaiserling. Immunhistochemische Darstellung von Lymphgefäßen mit D2–40 in der diagnostischen Pathologie , 2004, Der Pathologe.
[4] D. Jackson,et al. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. , 2004, Human pathology.
[5] Alexander Marks,et al. Hobnail hemangiomas (targetoid hemosiderotic hemangiomas) are true lymphangiomas , 2004, Journal of cutaneous pathology.
[6] A. Folpe,et al. Kaposiform Hemangioendothelioma: A Study of 33 Cases Emphasizing Its Pathologic, Immunophenotypic, and Biologic Uniqueness From Juvenile Hemangioma , 2004, The American journal of surgical pathology.
[7] R. Gausas,et al. Proliferation of D2-40-expressing intestinal lymphatic vessels in the lamina propria in inflammatory bowel disease. , 2004, International journal of molecular medicine.
[8] M. Skobe,et al. Molecular characterization of lymphatic endothelial cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[9] Alexander Marks,et al. A New Monoclonal Antibody, D2-40, for Detection of Lymphatic Invasion in Primary Tumors , 2002, Laboratory Investigation.
[10] Alexander Marks,et al. Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas , 2002, Modern Pathology.
[11] R. Jain,et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. , 2001, Cancer Research.
[12] S. Kumta,et al. Kaposiform Hemangioendothelioma: Five Patients with Cutaneous Lesion and Long Follow-Up , 2001, Modern Pathology.
[13] E. Mindell. Enzinger and Weiss’s Soft Tissue Tumors. 4th ed. , 2001 .
[14] A. Folpe,et al. Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3): A Marker of Vascular Tumors with Presumed Lymphatic Differentiation, Including Kaposi's Sarcoma, Kaposiform and Dabska-Type Hemangioendotheliomas, and a Subset of Angiosarcomas , 2000, Modern Pathology.
[15] Odile Enjolrasa,et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. , 2000 .
[16] K. Alitalo,et al. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors , 1999, Cancer.
[17] M. Karkkainen,et al. Vascular endothelial growth factor-C: a growth factor for lymphatic and blood vascular endothelial cells. , 1998, Trends in cardiovascular medicine.
[18] E. Tschachler,et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. , 1998, Cancer research.
[19] I. Frieden,et al. Kaposiform hemangioendothelioma : An aggressive, locally invasive vascular tumor that can mimic hemangioma of infancy , 1997 .
[20] J. Mulliken,et al. Thrombocytopenic Coagulopathy (Kasabach‐Merritt Phenomenon) Is Associated with Kaposiform Hemangioendothelioma and Not with Common Infantile Hemangioma , 1997, Plastic and reconstructive surgery.
[21] K. Alitalo,et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[22] N. Skakkebaek,et al. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[23] S. Weiss,et al. Kaposiform Hemangioendothelioma of Infancy and Childhood: An Aggressive Neoplasm Associated with Kasabach-Merritt Syndrome and Lymphangiomatosis , 1993, The American journal of surgical pathology.
[24] J. N. Schullinger. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy , 1992 .
[25] J. Mulliken,et al. Interferon alfa‐2a therapy for life‐threatening hemangiomas of infancy , 1992, The New England journal of medicine.
[26] N. Skakkebaek,et al. A novel maturation marker for human Sertoli cells. , 1989, International journal of andrology.
[27] K. Carraway,et al. O‐glycosylation pathway for mucin‐type glycoproteins , 1989, BioEssays : news and reviews in molecular, cellular and developmental biology.
[28] H. Kahn,et al. Production of a monoclonal antibody specific for seminomas and dysgerminomas. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[29] Xiaowei Xu,et al. Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix , 2005, Modern Pathology.
[30] L. Litzky,et al. Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma , 2005, Modern Pathology.
[31] D. Elder,et al. “D2-40 Immunoreactivity in Spindle Cell Tumors, a Specific Lymphatic Endothelial Marker?” , 2004 .
[32] M. Mihm,et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. , 2000, Human pathology.
[33] J. Mulliken,et al. Residual lesions after Kasabach-Merritt phenomenon in 41 patients. , 2000, Journal of the American Academy of Dermatology.
[34] J. Mulliken,et al. Vascular tumors and vascular malformations (new issues). , 1997, Advances in dermatology.
[35] H. Yeger,et al. Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours , 1999, British Journal of Cancer.